Table I.
Patients' baseline demographic data and clinical characteristics by olfactory status (n=111).
| Normosmics (n=36) | Hyposmics (n=56) | Anosmics (n=19) | p-value | |
|---|---|---|---|---|
| Age (mean ± SD) | 42.2 ± 13.2 | 50.2 ± 15.3 | 50.9 ± 13.1 | 0.028 |
| Gender %(n) | ||||
| Male | 44.4% (16) | 46.4% (26) | 47.4% (9) | |
| Female | 55.6% (20) | 53.6% (30) | 52.6% (10) | 0.974 |
| Clinical characteristics %(n) | ||||
| Nasal polyposis | 27.8% (10) | 28.6% (16) | 73.7% (14) | 0.001 |
| Asthma | 38.9% (14) | 30.4% (17) | 73.7% (14) | 0.004 |
| Aspirin intolerance | 2.8% (1) | 7.1% (4) | 26.3% (5) | 0.012 |
| Allergic rhinitis | 30.6% (11) | 26.8% (15) | 5.3% (1) | 0.096 |
| Septal deviation | 33.3% (12) | 30.4% (17) | 10.5% (2) | 0.170 |
| Hypertrophy turbinate | 8.3% (3) | 8.9% (5) | 5.3% (1) | 0.878 |
| Prior sinus surgery | 52.8% (19) | 66.1% (37) | 63.2% (12) | 0.435 |
| Smoker | 5.6% (2) | 5.4% (3) | 0(0) | 0.582 |
| Medication Usage %(n) | ||||
| Systemic | 19.4% (7) | 23.2% (13) | 31.6% (6) | 0.599 |
| corticosteroids | ||||
| Disease Severity Measures (mean ± SD) | ||||
| Lund-MacKay CT scores | 10.1 ± 6.0 | 11.8 ± 6.4 | 18.4 ± 5.0 | <0.001 |
| Lund-Kennedy endoscopy score | 5.1 ± 5.0 | 6.1 ± 4.4 | 9.4 ± 5.0 | 0.006 |